Stay updated with breaking news from B Merck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems in pregnant women.
The European Medicines Agency said it has received a request from Merck to authorize its coronavirus antiviral, the first pill shown to treat COVID-19.
The European Medicines Agency said it has received a request from Merck to authorize its coronavirus antiviral, the first pill shown to treat COVID-19.
Britain has granted a conditional authorization to Merck's coronavirus antiviral, the first pill shown to successfully treat COVID-19. It is the first country to OK the treatment, although it was not immediately clear how quickly the pill would be available.
Vaccines are the focus of the global fight against COVID-19, but a flurry of therapeutic breakthroughs and fights over a limited supply of antibody drugs are returning treatments back to the spotlight.